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Abstract
Objective: The use of continuous sedation until death for terminally ill cancer patients with unbearable
and untreatable psychological and existential suffering remains controversial, and little in-depth
insight exists into the circumstances in which physicians resort to it.
Methods: Our study was conducted in Belgium, the Netherlands, and the UK in hospitals, PCUs/
hospices, and at home. We held interviews with 35 physicians most involved in the care of cancer
patients who had psychological and existential suffering and had been continuously sedated until
death.
Results: In the studied countries, three groups of patients were distinguished regarding the origin of
their psychological and existential suffering. The ﬁrst group had preexisting psychological problems
before they became ill, the second developed psychological and existential suffering during their
disease trajectory, and the third presented psychological symptoms that were characteristic of their
disease. Before they resorted to the use of sedation, physicians reported that they had considered an
array of pharmacological and psychological interventions that were ineffective or inappropriate to
relieve this suffering. Necessary conditions for using sedation in this context were for most physicians
the presence of refractory symptoms, a short life expectancy, and an explicit patient request for
sedation.
Conclusions: Physicians in our study used continuous sedation until death in the context of psycho-
logical and existential suffering after considering several pharmacological and psychological interven-
tions. Further research and debate are needed on how and by whom this suffering at the end of life
should be best treated, taking into account patients’ individual preferences.
© 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.
Introduction
Continuous sedation until death (from here onwards
referred to as ‘sedation’) is considered to be a last
resort option to relieve unbearable and untreatable
(refractory) symptoms experienced by terminally ill
cancer patients [1–3]. It is deﬁned by sedation guide-
lines as the deliberate lowering of consciousness,
continuously until the patient’s death [1–3]. Sedation
guidelines indicate that wherever possible, the patient
(and/or the patient’s family) should be actively
involved in decision making and give consent for the
initiation of sedation. The purpose of sedation should
be symptom relief and not the hastening of death [1–3].
One of the key controversies about the practice of seda-
tion concerns its use for patients who have psychological
and existential suffering at the end of life [4,5]. Whereas
the literature lacks uniform terms and deﬁnitions of these
concepts, a common component includes nonphysical
suffering such as an overwhelming sense of meaningless,
hopelessness, (death) anxiety, panic, depression, sadness,
anhedonia, guilt, and/or lack of any interest [6–9]. Psycho-
logical and existential suffering is not uncommon among
end-stage cancer patients: depression and anxiety rates
© 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.
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range from, respectively, 3–77% and 13–79% [10]. Preva-
lence rates of cancer patients’ reported hopelessness or
demoralization, and losing one’s will to live or desire for
death range from, respectively, 7–41% and 2–26% [11].
As delirium may interfere with the recognition and control
of physical and psychological symptoms, its presence
should be ruled out or treated appropriately [12].
Sedation for psychological and existential suffering is
considered controversial for a number of reasons. Unlike
physical symptoms, it is more difﬁcult to assess whether
this suffering is truly refractory because of its subjective
nature and a lack of well-established assessment tools
[3,5,13]. The European Association for Palliative Care
recommends in its framework for the use of palliative
sedation that psychological and existential distress
should be conﬁrmed by mental healthcare professionals
after trials of appropriate therapy such as intermittent
sedation. Only after repeated trials of intermittent
sedation, continuous sedation could be considered [3].
These recommendations are in line with the Belgian
and Dutch sedation guidelines [1,2].
A few quantitative studies have addressed the issue of
using sedation for the relief of psychological and existen-
tial suffering of severely ill patients. According to Dutch
physicians, existential suffering, anxiety, and depression
were amongst the indications for sedation mentioned for
respectively 29%, 13%, and 30% of the patients [14].
British physicians reported that in 25% of the cases in
which their patient had been continuously and deeply
sedated, sedation had been given because of the patient’s
intractable psychological suffering (whether or not in
combination with other reasons) [15]. In addition, a few
case studies addressing this issue concluded that sedation
is a useful but controversial method for treating psycho-
logical and existential suffering at the end of life but that
further research is needed on the causes and therapeutic
options for this suffering [13,16–18].
There is little in-depth insight in the circumstances in
which physicians resort to the use of sedation for terminally
ill patients with psychological and existential suffering. We
performed comparative qualitative, case-based studies in
three European countries with different legal, policy, and
service delivery frameworks. We aimed to give insight into
physicians’ considerations about and descriptions of the use
of sedation for cancer patients who had psychological and
existential suffering at the end of life.
Methods
This qualitative interview study is part of the larger UK –
Netherlands – Belgium InternAtional SEDation (UNBI-
ASED) study in which in-depth interviews were held with
physicians, nurses, and relatives in Belgium, the Netherlands,
and the UK in 2011–2012 in hospitals (oncology wards),
PCUs (Belgium) or hospices (UK and the Netherlands), and
at home. We refer to the published study protocol for a full
description of the methods used [19].
Study design, setting, and participants
This paper concerns the physician interviews in the three
countries. Physicians were invited to take part in a face-
to-face interview if they had recently taken a key role in
the care of (i) a patient aged over 18 years; (ii) who had
died of cancer; and (iii) who had been continuously
sedated until death. We did not ask physicians how the
process of continuous sedation was monitored. Senior
clinical staff identiﬁed decedents who met the inclusion
criteria and nominated physicians. Physicians in the three
countries were interviewed about no more than four
patients. If more than one physician was involved, the
other involved physician was also interviewed if possible.
Procedures
All physicians gave their informed consent to the audio
taping of the interview. At the beginning of each interview,
patient’s and physician’s sociodemographic information
was obtained via the physician. Patient’s anonymity was
preserved. The interviews were semi-structured, supported
with the use of aide-memoires that focused on physicians’
recollections of the decedent’s care and the use of sedation
in particular and their general attitudes regarding sedation.
Analysis
All recordings of the interviews were transcribed verbatim,
and all data that could identify the physicians were removed
to preserve anonymity. The Belgian and Dutch interviews
were translated into English by a professional translation
bureau and checked for accuracy. One researcher (L.A.)
selected all physician interviews in which the physician
reported on the use of sedation for patients with psycholog-
ical and existential suffering. This was checked by a senior
researcher (J.A.C.R.). All interviews were read by L.A. and
J.A.C.R., and main themes were identiﬁed. A coding tree
was designed and agreed upon on the basis of the main
themes. The interviews were reread, and quotes were
selected and classiﬁed under the matching main themes by
L.A. and J.A.C.R. The development of the analysis was
discussed with all the coauthors in telephone meetings.
Qualitative analysis software (NVIVO 9; QSR International
Pty Ltd., 2010) was used to organize the data. Finally,
quotes per main theme were selected by L.A. and J.A.C.R.
for publication and were approved by all researchers.
Results
For the present study, we explored 39 cases of patients with
cancer who had psychological and existential suffering
according to the physician (18 Belgium, 12 the Netherlands,
540 L. Anquinet et al.
© 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd. Psycho-Oncology 23: 539–546 (2014)
DOI: 10.1002/pon
and 9 UK), involving 35 physicians (13 Belgium, 11 the
Netherlands, and 11 UK). Characteristics of patients and
physicians can be found in Table 1. In this results section,
we report on physicians’ descriptions of the various types
and origins of patients’ suffering before sedation, the
healthcare professionals and relatives involved and inter-
ventions used to manage psychological and existential suf-
fering before sedation, and the conditions identiﬁed by
physicians as necessary for the initiation of sedation.
Types of suffering
Physicians in the studied countries described a broad
range of symptoms that patients experienced before they
were sedated. Physical symptoms included mainly pain,
dyspnea, (terminal) agitation, cachexia, or fatigue. Psycho-
logical symptoms included panic, anxiety, depression or
sadness, and paranoia. Existential suffering included
demoralization, despondency, sense of dependency, having
difﬁculties being on the decline, loss of will to live, hope-
lessness, being ‘battle-weary’, being [mentally] exhausted,
and death anxiety.
On the basis of the physicians’ accounts, we identiﬁed a
continuum of patients who, at one end, suffered mainly
from physical symptoms, over patients who suffered from
a combination of psychological, existential, and physical
symptoms, to patients who suffered predominantly psy-
chologically and existentially (Table 2).
UK, GP, case 37: Quite a lot of her distress was psycho-
logical because she didn’t want the children to see her ill
[and] to know that she was ill. She developed intractable
headache, intractable vomiting and some sort of gradual
ﬁxed extension of her neck that we think was metastases
at the back of her neck.
Several physicians suspected that the presence of some
physical symptoms was related to and may have increased
the psychological and existential suffering and vice versa.
UK, palliative care physician n°2, case 32: The patient had
a lot of problems with anxiety and pain which were very
difﬁcult to control all the way along. So there was felt to
be quite a large psychological element to it. He was very
anxious about his pain and therefore his anxiety made
the pain worse and vice versa.
In patients who suffered predominantly psychologically
and existentially, physical symptoms were also part of the
clinical picture but were sufﬁciently alleviated.
Interviewer: So the pain was well controlled but the fatigue…
Belgium, Oncologist, case 19: It actually was his psycho-
logical burden… he could no longer continue.
We could not identify different patterns between the
countries in perceived presence of psychological, existential,
and physical symptoms.
Origin of psychological and existential suffering
The origin of patients’ psychological and existential
suffering varied in the opinion of physicians. We distin-
guished three pathways. The ﬁrst pathway concerned
patients who already suffered from psychological problems
such as depression, anxiety, or mourning for the death of
their partner before they become (terminally) ill.
Belgium, palliative care physician, case 7: At admission,
there was another symptom that we didn’t know about
Table 1. Characteristics of patients and physicians
Patients N=39 Physiciansa N= 35
Country 18
Belgium 12 13
the Netherlands 9 11
UK 11
Care setting
Hospital 10 7
Home 14 13
PCU/hospice 15 15
Age (years)
<40 2 10
41–50 0 10
51–60 9 8
61–70 9 2
71–80 14 0
>80 5 0
Not stated 0 5
Gender
Male 20 19
Female 19 16
Specialism n/a
Primary care 12
Palliative home care team 2
Hospital 2
Palliative support team hospital 5
Palliative care/hospice care 14
Diagnosis n/a
Abdominal/stomach 2
Bladder/renal 4
Colo-rectal 6
Brain/glioblastoma 1
Breast 2
Gynecological 3
Facial maxillary/esophageal 2
Gall bladder/pancreatic 2
Leukemia/myeloﬁbrosis/myeloma 2
Lung/mesothelioma 8
Melanoma 2
Peritoneal 1
Prostate 1
Sarcoma 1
Unknown primary 2
n/a, not applicable.
aMore than one physician could have been interviewed.
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from before. There was a pronounced problem of fear, that
lady took antidepressants, so throughout her life she had
been depressed.
Patients to whom the second pathway applied developed
psychological and existential suffering during their disease
trajectory as a reaction to their decline and approaching of
death. In this second group, there were two subgroups with
regard to the patients’way of coping with their approaching
end. Patients of the ‘resigned’ subgroup usually appeared
to have accepted that they were going to die soon and were
often described to have had ‘enough of it’.
Belgium, oncologist, case 5: The patient asked the question
and took the decision. ‘I want to sleep, I do not want to wake
up anymore’. He was just totally bedridden, he couldn’t do
anything anymore, he had no quality of life and he also
had a very bad life expectancy. He just had enough.
The ‘resistance’ subgroup did not appear to have accepted
that they were ill or dying and were described as angry,
anxious, and in panic, not wanting to be dependent on others
and ﬁnding it hard to accept that their health was declining.
Netherlands, palliative care physician, case 29: The pain
was well controlled, but the man had a fear of going to
bed, because if he went to bed he could die. He was very
afraid of that. He was really ﬁghting it.
The third pathway concerned patients whose psycho-
logical symptoms were described as a direct result of their
disease. Examples are patients who suffered from a neuro-
logical deﬁcit because of a brain tumor, with aggressive
behavior, agitation, or confusion as a consequence. They
were often not (fully) competent anymore according to
the physicians.
Belgium, palliative care physician, case 3: Sedation was
used for obvious symptoms of fear, paranoia, suspicion,
aggression and a very difﬁcult communication in the context
of a central tumor with severe communication disorders.
Management of psychological and existential suffering
Physicians in the three countries described how they had
managed the patient’s psychological and existential suf-
fering before using sedation. They described three groups
of carers that were involved and who had used several
psychological as well as pharmacological interventions.
The ﬁrst group of carers consisted of general healthcare
professionals such as the physician himself/herself, other
physicians, and nurses. A pharmacological intervention
described was the administration of medication such as
anxiolytics, antidepressants, or benzodiazepines (in smaller
dosages).
UK, GP n°1, case 38:We give people diazepam in exactly the
same way that we would use diazepam for acute anxiety and
psychological distress in people who weren’t terminally ill.
Sometimes, intermittent sedation had been used by phy-
sicians as a ‘time-out’.
UK, palliative care physician, case 34: Talking and com-
municating is one side of it but you can’t be there all the
time and the patient just wants some time out. We some-
times talk about it in those terms with the patient: ‘When
things are getting really on top of you, an injection that
will put you to sleep, might just help you get over that
really bad period. That will give you a sleep for four, six
hours, but then when you wake up we can see how things
are then.’ And patients and doctors often refer to that as
giving somebody Midazolam [a sedative] for time out.
Not all physicians had used medication to alleviate the
suffering. One of them explained that drug treatment for
psychological symptoms needs several weeks to take
Table 2. Summary of main results
Continuum of suffering
From patients mainly suffering from physical symptoms to patients
predominantly suffering psychologically and existentially
Three origins of psychological and existential suffering 1. Patients who already suffered from psychological problems before they became ill
2. Patients who developed psychological and existential suffering during their disease trajectory as a
reaction to their decline and approaching of death
2a. Resigned subgroup: patients who appeared to have accepted that they were going to die soon
2b. Resistance subgroup: patients who did not appear to have accepted that they were ill or dying
3. Patients whose psychological symptoms were described as a direct result of their disease
Three groups of carers involved in the management of
psychological and existential suffering
1. General healthcare professionals such as the physician himself/herself, other physicians, and nurses
2. Mental healthcare professionals such as psychiatrists and psycho-oncologists
3. Relatives
Three conditions for the use of sedation 1. Refractory (physical) symptoms
2. The patient’s short life expectancy
3. The patient’s explicit request for the use of sedation
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effect, while the patient only had days to live. The physi-
cian added that drug treatment of psychological symptoms
in terminally ill patients may meet additional effectiveness
problems, for example, when the liver fails to metabolize
medications.
Netherlands, oncologist, case 21: The problem was that a
drug treatment for depression needs at least several weeks
to take effect. And because her liver was not working, you
cannot give her medication. So her depression was not
treatable with medication.
Sometimes, psychological interventions such as talking
and spending extra time with the patient had been applied.
UK, palliative care physician n°3, case 31: He was a
gentleman who the team probably spent more time than
average with, because he was anxious we tried using more
conservative measures. Sometimes just talking things
through with patients can be quite effective.
Some other physicians stated that nurses tended to be
more involved in the psychological management than they
themselves.
UK, palliative care physician, case 39: The nurses tend to
do maybe a bit more of the psychological and social issues.
Although, clearly there’s a big overlap and we all do a bit
of everything. But that’s the way we tend to divide it up.
Furthermore, psychological interventions were not by
all physicians deemed suitable for all patients, for in-
stance, because the patient needs to have sufﬁcient energy,
should be competent, must not be too exhausted and
should want to get involved.
Belgium, palliative care physician, case 18: As a doctor
you can reasonably estimate what can still be done and
what can’t. And to what extent the patient still wants,
and still brings up the energy to get started with some-
thing. Because for a psychologist, or a consultant, the
patient must indeed certainly still have a clear capacity
of thinking and not be too tired.
The second group of carers who was involved in the
management of the patient’s psychological and existential
suffering included mental healthcare professionals. These
concerned psychiatrists, psychologists, psycho-oncologists,
counselors, and pastors. Their main involvement concerned,
according to the respondents, talking to the patient (or the
patient’s family).
UK, palliative care physician, case 31: The other people
we involved were the psychiatrist, because he’d had
depression and he’d been depressed for some time before
he became ill. He’d also seen the psycho-oncologist when
he came in, and [she/he] just talked to him.
Sometimes, a psychiatrist had been called in by the phy-
sician to determine the refractory nature of a psychologi-
cal symptom.
Netherlands, oncologist, case 21: In extensive consulta-
tions with the psychiatrists we determined that the depres-
sion was refractory because we had no options to treat it.
However, not all physicians reported on the involve-
ment of a specialist, and some said explicitly that they
had not done so.
Belgium, palliative care physician, case 18: The moral
counsellor, that’s something we seldom use, this is a Cath-
olic hospital. They’re there, but they [psychologist and
moral counsellor] are not involved that much, unless the
patient really wants it.
The third group was the patient’s relatives. They were
described as talking to and supporting the patient.
Belgium, GP, case 10: I had the impression that we were
lucky that the informal care provided by the family was
very good, that it made the patient very calm.
Similar types and treatments of psychological and exis-
tential suffering and groups of carers involved in these treat-
ments were reported by physicians in all three countries.
Conditions for the use of sedation
Several physicians described that for them, a condition for
the initiation of sedation for psychological and existential
suffering was the presence of refractory symptoms.
Netherlands, oncologist, case 21: Frankly, we were a bit
happy that the lady had refractory symptoms. Initially we
said sedation is not possible, because we do not have
refractory symptoms.
Moreover, the presence of physical refractory symp-
toms was an important condition to perform sedation for
most, but not all, physicians.
Netherlands, oncologist, case 21: Terminal restlessness,
delirium, dyspnoea and pain. These are the most common
reasons for someone to sedate. I had never experienced
using sedation for refractory depression, and I think in
our unit it is also unprecedented.
Some said that they would be reluctant to sedate for
mainly psychological and existential suffering; and some
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said that in the case of psychological symptoms, they
would wait until some refractory physical symptoms arise.
Interviewer: You said that those physical problems must
also increase before you start with the sedation?
Belgium, palliative care physician, case 18: Yes. Purely
based on psychological symptoms is a lot harder, the phys-
ical deterioration must most certainly be there as well.
Yet, the refractory nature of symptoms was not for all
physicians a necessary condition for the use of sedation.
Netherlands, palliative care physician, case 20: I just
couldn’t put my ﬁnger on what it was. It was behavior that
was not possible to correct, in which she lingered, where
she was frightened. I’m not sure whether it was a delirium,
or behavioral disorders that can occur from the stroke. My
colleague said: you’re really with your back up against a
wall here. You do not really have a refractory symptom,
but by God you have no idea what else you could possibly
do about this. Do you have to interpret the guidelines so
broadly? That sometimes makes it difﬁcult.
Similar results were found in each of the studied countries.
Another condition that was frequently described in the
three countries was a patient’s short life expectancy.
Interviewer: What are the criteria [for the use of sedation]
you uphold?
Netherlands, palliative care physician, case 19: First that’s
a life expectancy of less than two weeks. I usually keep to
a week, because death needs to be close by.
This condition was more present in the accounts of
Dutch and British physicians compared with what Belgian
physicians reported.
A last condition according to several physicians was
patient’s explicit request for the use of sedation or request
to be asleep and not wake up anymore.
Belgium, palliative care physician, case 18: So [among the
indications for sedation are] a [short] prognosis, and a second
point of course is that the patient asks for it [sedation].
Discussion
This study provides insight into physicians’ experiences
with continuous sedation until death in the context of
psychological and existential suffering, physicians’ reported
management of this suffering, and conditions identiﬁed by
physicians as necessary before resorting to sedation at the
end of life.
Our study beneﬁted from the use of in-depth face-to-
face interviews, allowing us to explore physicians’ experi-
ences and perspectives on a highly debated subject.
However, our results cannot be generalized in a statistical
way to the whole population of physicians or to physician
specialty in particular because of the relatively small
number of cases and interviews. Instead, our ﬁndings
may provide insights that may be transferrable to similar
clinical cases and contexts. Additionally, our data gathered
by interviews are dependent on the subjective experience
and interpretation of both the physician and the interviewer.
Although our retrospective design does not preclude recall
bias, this is limited in most of the cases by minimizing the
time between the patient’s death and the interview with
the physicians to 2 months. In a few cases, this was longer
than 2 months, and the risk of recall bias could have been
larger in these cases.
Physicians in the three countries had used sedation for a
continuum of patients who were mainly suffering from
physical symptoms to patients predominantly suffering
psychologically and existentially. The patients’ psycho-
logical and existential suffering could have been present
before the patient became (terminally) ill or developed
and worsened during the patient’s disease trajectory. As
stated by the respondents and conﬁrmed by literature,
the existence of (unrelieved) physical symptoms may have
led to the psychological and existential suffering and vice
versa [8].
In the accounts of the physicians, the various manners
in which they had attempted to relieve the patient’s psy-
chological and existential suffering and the considerable
efforts that this often took were central. In several of our
case studies, in addition to being near the patient and
building a trusting relationship, physicians had involved
mental healthcare professionals, and they often had
administered medication or intermittent sedation to relieve
suffering before using continuous sedation. Similar inter-
ventions were reported by physicians in a Japanese study
in PCUs for terminally ill cancer patients suffering from
refractory psycho-existential issues before sedation [7].
In the literature, a number of psychotherapeutic interven-
tions have been proposed, such as cognitive–behavioral
therapy, group therapy, existential therapy, and psycho-
education, but research does not seem to support the value
of one approach over others in cancer patients [9,20].
Nevertheless, our study shows that pharmacological
and psychological interventions may not be effective or
appropriate for all patients. Physicians reported that phar-
macological therapies other than sedation were considered
but were precluded by the patient’s short life expectancy
or liver failure. It is supported by the literature that drug
therapy takes time to have effect and that drug metabolism
may be altered and decreased because of an organ failure
in terminally ill patients [21,22]. Recently however, there
has been renewed interest, especially in the United States,
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in the use of psychostimulants for treating depression in
physically ill patients. Although the evidence base is still
limited, its use has been recommended because of its
potential to enhance mood, energy, and arousal within
hours [23]. Also, antipsychotics may help reduce delirium
symptoms as well as psychological symptoms [24]. Intra-
venous Ketamine, an analgesic, has also been shown to
contribute to the rapid treatment of depressive symptoms
in palliative patients [25].
A main condition for the initiation of sedation for
psychological and existential suffering was for most
physicians the presence of refractory symptoms. This con-
forms with the sedation guideline recommendations [1–3].
There was often reluctance among physicians in the stud-
ied countries to sedate for mainly psychological and exis-
tential suffering. Another study also found physicians to
be less in favor of or opposed to using sedation to uncon-
sciousness for existential suffering [26]. Physicians in our
study explained that they were reluctant to use sedation in
these cases for personal reasons and that they would wait
for the appearance of coexisting refractory physical symp-
toms. It is also possible that physicians are reluctant to use
sedation for psychological and existential suffering be-
cause this suffering may ﬂuctuate as death approaches
and is usually amenable to pharmacological and psycho-
logical treatments such as the dignity model intervention
designed for patients at the end of life [27,28]. This reluc-
tance may heighten the risk of not exploiting enough the
potential for interventions. Further, for the physicians in
our study, the patient’s short life expectancy and an
explicit request to be asleep and not to wake up again were
deemed as important. No differences were found between
the studied countries, except that the patient’s short life
expectancy as a condition for the use of sedation seemed
less important for Belgian physicians. This does not
conform with sedation guideline recommendations [1–3].
Possibly, these physicians primarily focused on adequate
symptom relief regardless of the patient’s short life
expectancy.
In conclusion, physicians in our study resorted to the
use of continuous sedation until death for cancer patients
with psychological and existential symptoms after consid-
ering several pharmacological and psychological interven-
tions and involving healthcare professionals. Extensive
debate and research on when, how, and by whom psycho-
logical and existential suffering at the end of life should be
best treated are urgently needed, taking into account the
individual differences between patients regarding their
preferences and wishes and healthcare status [9]. Studies
should focus on how mental healthcare can be most
effectively incorporated into routine medical care and
especially palliative care, taking into account patients’
individual preferences [29,30]. As several studies have
shown that existential distress such as demoralization
and hopelessness is linked to terminally ill patients’ desire
for death, ethical debate should focus on whether and
under which circumstances a far reaching medical practice
such as continuous sedation until death is a desirable
response to psychological and existential suffering at the
end of life [31,32].
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